BN Business News
Add your company to Business Communicator →

Business · 27/11/2024Updated: 10/17/2026 · 1 min read

FDA Announces Draft Guidance on Ovarian Toxicity in Premenopausal Adults During Oncologic Drug Development

Summary

The FDA has released a draft guidance for industry on assessing ovarian toxicity in premenopausal adults participating in cancer clinical trials, aiming to inform decision-making on anti-cancer treatments.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →